Companies / Health Care / Pharmaceuticals
Bristol Myers Squibb stock buybacks
BMY—No share repurchases in the company’s standard SEC financial data for the last twelve months.
Bristol Myers Squibb’s filings haven’t reported share repurchases in standard form since Q4 2024.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $0 |
| Q4 '20 | $1.5B |
| Q1 '21 | $1.8B |
| Q2 '21 | $1.2B |
| Q3 '21 | $525M |
| Q4 '21 | $2.8B |
| Q1 '22 | $5B |
| Q2 '22 | $0 |
| Q3 '22 | $701M |
| Q4 '22 | $2.4B |
| Q1 '23 | $250M |
| Q2 '23 | $905M |
| Q3 '23 | $4B |
| Q4 '23 | $0 |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $0 |
| Q4 '24 | $0 |
| Q1 '25 | $0 |
| Q2 '25 | $0 |
| Q3 '25 | $0 |
| Q4 '25 | $0 |
| Q1 '26 | $0 |
| Q2 '26 | $0 |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 2.29B |
| Q4 '20 | 2.22B |
| Q1 '21 | 2.27B |
| Q2 '21 | 2.25B |
| Q3 '21 | 2.24B |
| Q4 '21 | 2.22B |
| Q1 '22 | 2.16B |
| Q2 '22 | 2.15B |
| Q3 '22 | 2.15B |
| Q4 '22 | 2.12B |
| Q1 '23 | 2.11B |
| Q2 '23 | 2.10B |
| Q3 '23 | 2.06B |
| Q4 '23 | 2.03B |
| Q1 '24 | 2.02B |
| Q2 '24 | 2.03B |
| Q3 '24 | 2.03B |
| Q4 '24 | 2.02B |
| Q1 '25 | 2.04B |
| Q2 '25 | 2.04B |
| Q3 '25 | 2.04B |
| Q4 '25 | 2.04B |
| Q1 '26 | 2.05B |
| Q2 '26 | 2.05B |
$0last quarter (Q2 2026)
−$553Mnet of stock compensation ($553M)
+0.5%diluted shares, 1 year
−9.7%diluted shares, 5 years
$5.1Bdividends, 12 months
0%of free cash flow ($11.4B) spent on buybacks
$0raised by issuing stock, 12 months
$5.0Bleft under its authorization as of Dec 31, 2025
Bristol Myers Squibb’s recent filings don’t report repurchases in the standard XBRL fields we read. That usually means it didn’t buy back stock, but some companies report buybacks only in custom fields. Check its latest 10-Q to be sure.
By fiscal year
Questions
- Does Bristol Myers Squibb buy back its stock?
- Bristol Myers Squibb’s filings haven’t reported share repurchases in standard form since Q4 2024.
- How much did Bristol Myers Squibb spend on buybacks in fiscal 2025?
- $0, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Bristol Myers Squibb's share count going down?
- Its diluted share count changed −9.7% over five fiscal years and +0.5% over the last year.
- Does Bristol Myers Squibb have a buyback authorization?
- Its filings show $5.0B remaining under its repurchase authorization as of Dec 31, 2025.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Jul 30, 2026 · open on SEC.gov